Seasonality Snapshot

Royalty Pharma (RPRX)

Pharma Royalties · US · US Healthcare & Biotech
✓ VERIFIED · 7YR REAL DATA
JanFebMarAprMayJunJulAugSepOctNovDec
NEUTRAL SEASONALITY — July
Strongest Month
November
+5.02% avg · 83% win rate
Weakest Month
September
-3.64% avg · 17% win rate
MonthAvg ReturnWin Rate
January +4.37% 67%
February +2.72% 50%
March -1.69% 50%
April +1.46% 67%
May -0.88% 33%
June +0.76% 67%
July NOW -0.08% 71%
August -1.30% 33%
September -3.64% 17%
October +0.47% 50%
November +5.02% 83%
December +0.60% 50%
These figures are computed from 7 years of actual monthly closing prices. Past seasonal patterns are not a guarantee of future performance. See our methodology for how this is calculated, or visit the Academy to learn how to read seasonal data responsibly.

Royalty Pharma seasonality — common questions

What is Royalty Pharma's best month historically?
Historically, November has been Royalty Pharma's strongest month, averaging +5.02% with a 83% win rate over 7 years of data. September has been the weakest at -3.64%.
Is Royalty Pharma seasonal?
Royalty Pharma shows a measurable seasonal pattern: its best and worst months differ by 8.66 percentage points on average. These figures come from 7 years of real monthly closing prices. Seasonality is a historical tendency, not a prediction.
How does Royalty Pharma historically perform in July?
Royalty Pharma is currently in July, which has historically averaged -0.08% with a 71% win rate. That is a historically neutral window.

Get the full analysis

Backtest this seasonal pattern, compare it against other assets, set alerts, and explore detrended & presidential-cycle views.

Open the Analyzer →
TimingAX is an independently operated service, not a registered investment adviser. This page is for informational purposes only and is not financial advice.